Validation of the BASED Score as a Prognostic Biomarker for Refractory Epilepsy Following Treatment of Infantile Epileptic Spasms Syndrome

BACKGROUND AND OBJECTIVES: Refractory epilepsy is common among children with a history of infantile epileptic spasms syndrome (IESS), yet no validated prognostic biomarkers exist to guide early risk stratification. The Burden of Amplitudes and Epileptiform Discharges (BASED) score is an interictal EEG rating scale for children with IESS, with scores of 4 or 5 suggesting epileptic encephalopathy. The objective of this study was to determine whether a post-treatment BASED score of 4/5 is a prognostic biomarker for refractory epilepsy after IESS treatment. METHODS: This retrospective validation study of children with IESS was conducted at a Level 4 pediatric epilepsy center. Children with tuberous sclerosis complex (TSC) were excluded. Three blinded reviewers assigned 2021 BASED scores to full-length post-treatment EEGs. Refractory epilepsy was defined as persistent seizures despite treatment with at least 2 antiseizure medications or completion of epilepsy surgery. Prespecified performance benchmarks for BASED 4/5 as a rule-in test required ≥80% specificity and a positive likelihood ratio of ≥4. RESULTS: = 0.78). Half (52%) of the children had refractory epilepsy. BASED 4/5 demonstrated high specificity (88.1%, 95% CI 77.1-95.1) for refractory epilepsy, with a positive likelihood ratio of 4.4 (2.1-9.1). The sensitivity, positive predictive value, and negative predictive value were 51.6% (38.7-64.3), 82.5% (69.3-90.8), and 62.7% (56.1-68.7), respectively. An exploratory composite indicator comprising BASED 4/5, persistent epileptic spasms, and/or epileptic spasms relapse demonstrated higher sensitivity (79.7%, 67.8-88.7) with modestly reduced specificity (81.4%, 69.1-90.3). DISCUSSION: Study limitations include the single-center design, exclusion of children with TSC, variable EEG timing, and shorter follow-up in some children. Nevertheless, in this independent validation cohort, a post-treatment BASED 4/5 demonstrated favorable prognostic performance consistent with its proposed use as a rule-in test for refractory epilepsy. These findings support a post-treatment BASED score of 4/5 as a prognostic biomarker for refractory epilepsy after IESS treatment.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2026-11-17
DOI
https://doi.org/10.1212/wnl.0000000000218751
Citations
1
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
2.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Validation of the BASED Score as a Prognostic Biomarker for Refractory Epilepsy Following Treatment of Infantile Epileptic Spasms Syndrome

Corinne McCabe, Amanda Weber, John R. Mytinger, Purva R. Choudhari et al.
1 citations
Neurology
Epilepsy research and treatment
2.64
article

Validation of the BASED Score as a Prognostic Biomarker for Refractory Epilepsy Following Treatment of Infantile Epileptic Spasms Syndrome

Corinne McCabe, Amanda Weber, John R. Mytinger, Purva R. Choudhari, Steve Rust, Christopher W. Beatty, Jorge A. Vidaurre, Dara V.F. Albert, Anup D. Patel, Shawn C. Aylward, Megan M. Fredwall, Warren David Lo
article en
1 citations

Abstract

BACKGROUND AND OBJECTIVES: Refractory epilepsy is common among children with a history of infantile epileptic spasms syndrome (IESS), yet no validated prognostic biomarkers exist to guide early risk stratification. The Burden of Amplitudes and Epileptiform Discharges (BASED) score is an interictal EEG rating scale for children with IESS, with scores of 4 or 5 suggesting epileptic encephalopathy. The objective of this study was to determine whether a post-treatment BASED score of 4/5 is a prognostic biomarker for refractory epilepsy after IESS treatment. METHODS: This retrospective validation study of children with IESS was conducted at a Level 4 pediatric epilepsy center. Children with tuberous sclerosis complex (TSC) were excluded. Three blinded reviewers assigned 2021 BASED scores to full-length post-treatment EEGs. Refractory epilepsy was defined as persistent seizures despite treatment with at least 2 antiseizure medications or completion of epilepsy surgery. Prespecified performance benchmarks for BASED 4/5 as a rule-in test required ≥80% specificity and a positive likelihood ratio of ≥4. RESULTS: = 0.78). Half (52%) of the children had refractory epilepsy. BASED 4/5 demonstrated high specificity (88.1%, 95% CI 77.1-95.1) for refractory epilepsy, with a positive likelihood ratio of 4.4 (2.1-9.1). The sensitivity, positive predictive value, and negative predictive value were 51.6% (38.7-64.3), 82.5% (69.3-90.8), and 62.7% (56.1-68.7), respectively. An exploratory composite indicator comprising BASED 4/5, persistent epileptic spasms, and/or epileptic spasms relapse demonstrated higher sensitivity (79.7%, 67.8-88.7) with modestly reduced specificity (81.4%, 69.1-90.3). DISCUSSION: Study limitations include the single-center design, exclusion of children with TSC, variable EEG timing, and shorter follow-up in some children. Nevertheless, in this independent validation cohort, a post-treatment BASED 4/5 demonstrated favorable prognostic performance consistent with its proposed use as a rule-in test for refractory epilepsy. These findings support a post-treatment BASED score of 4/5 as a prognostic biomarker for refractory epilepsy after IESS treatment.

NeurologyVol. 107(12)
Nationwide Children's Hospital (US), The Ohio State University (US)
Nationwide Children's Hospital
Good health and well-being
Openalex Percentile: Top 18%
Epilepsy research and treatment
2.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon